William H. Frishman, M.D.

Professor, MedicineProfessor, PharmacologyChair Emeritus, Medicine School of Medicine
Square

William H. Frishman, M.D., has received national recognition for excellence in teaching. He is a recipient of the Medical Humanism Award from the Association of American Medical Colleges and a Mastership of the American College of Physicians. Dr. Frishman is a practicing internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology and geriatrics. He has authored and co-authored more than 900 original articles, reviews and book chapters. He has also edited, co-edited, authored and co-authored twelve full-length textbooks, including a major text, Cardiovascular Pharmacotherapeutics (McGraw-Hill) now in its second edition. He published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007) and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.

Areas of Expertise

  • Cardiovascular pharmacology
  • Clinical epidemiology 
  • Geriatrics

Education

  • M.D., Boston University School of Medicine

Honors and Awards

  • Teaching Scholar Award of the American Heart Association
  • The Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
  • The Distinguished Teacher Award from the Association of American Medical Colleges and Alpha Omega Alpha
  • The National Medical Honor Society

Research

Dr. Frishman has served as a principal investigator in multiple NIH funded studies including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Womens Health Initiative Trial" (WHI) and the "Bronx Longitudinal Aging Study."

Publications

  • Agrawal A, Gupta R, Arockiam AD, et. al. "Intravascular Lithotripsy for Coronary Artery Calcification: An Expert Review." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000000836
  • Khan RS, Frishman WH. "The Paradise Renal Denervation System: An FDA-approved catheter-based treatment option for resistant hypertension." Cardiology in review, (), (2024) . doi: 10.1097/CRD.0000000000000804
  • Anand SC, Furqan M, Tonelli AR, et. al. "Sotatercept: A New Era in Pulmonary Arterial Hypertension." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000000837
  • Chand S, Bujala N, Garg J, et. al. "Optimizing Outcomes in Transcatheter Aortic Valve Replacement Addressing Cerebrovascular Complications and Enhancing Patient Safety." Cardiology in review, (), (2024) . doi: 10.1097/CRD.0000000000000849
  • Nakhla M, Ahmed MS, Bishara R, et. al. "Incidence, Mechanism, and Management of Atrial Ablation Procedure Complications: A Literature Review." Cardiology in review, (), (2024) . doi: 10.1097/CRD.0000000000000842
  • Banerji B, Parikh MA, Minkin R, et. al. "Iloprost: Old and New Indications." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000000839
  • Maheta D, Agrawal SP, Patel J, et. al. "Curbside Consult Optimizing Statin Therapy in the Elderly: A Personalized Approach to Cardiovascular Disease Prevention." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000000848
View All Publications